Shining a light on cancer

We are developing a multi-cancer platform powered by our Dxcover AI Engine, with first application in earlier diagnosis of brain tumors.

Anchor 1

To be a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life.

Dxcover Raises $11.9m in Series A and Grant Funding to Accelerate Liquid Biopsy to Market

Enables CE Marking of blood test for brain cancer and advances colorectal cancer development Glasgow, Scotland, February 1, 2023 Dxcover...

Dxcover Secures Grant from the European Innovation Council

Grant enables pivotal multi-centre study for CE Marking of Dxcover Brain Cancer Liquid Biopsy Dxcover Limited, a clinical stage...

Effective Early Detection of Pancreatic Cancer Using Infrared Spectroscopy

Study published in Cancers demonstrates how simple, minimally invasive and accurate approaches can represent a powerful aid in earlier...